Drug
Bedaquiline (B)
Bedaquiline (B) is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(40%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_3
2
40%
Ph phase_2
2
40%
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(5)
Detailed Status
Recruiting2
Not yet recruiting2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 32 (40.0%)
Trials by Status
recruiting240%
not_yet_recruiting240%
enrolling_by_invitation120%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_3
A PAN-USR TB Multi-Center Trial
NCT06905522
enrolling_by_invitationphase_1
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
NCT07228702
recruitingphase_2
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT06114628
not_yet_recruitingphase_2
Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis
NCT07129629
not_yet_recruitingphase_3
Ultra-Short Regimen for Elderly DS-TB
NCT07076225
Clinical Trials (5)
Showing 5 of 5 trials
NCT06905522Phase 3
A PAN-USR TB Multi-Center Trial
NCT07228702Phase 1
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
NCT06114628Phase 2
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT07129629Phase 2
Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis
NCT07076225Phase 3
Ultra-Short Regimen for Elderly DS-TB
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5